These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28183330)

  • 1. Th17 and CD24
    Salomon S; Guignant C; Morel P; Flahaut G; Brault C; Gourguechon C; Fardellone P; Marolleau JP; Gubler B; Goëb V
    Arthritis Res Ther; 2017 Feb; 19(1):33. PubMed ID: 28183330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1
    Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
    Front Immunol; 2018; 9():2241. PubMed ID: 30327652
    [No Abstract]   [Full Text] [Related]  

  • 3. Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.
    Picchianti Diamanti A; Rosado MM; Scarsella M; Germano V; Giorda E; Cascioli S; Laganà B; D'Amelio R; Carsetti R
    Clin Exp Immunol; 2014 Sep; 177(3):630-40. PubMed ID: 24773026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus selectively increases circulating Treg cell numbers and restores the Th17/Treg balance in rheumatoid arthritis patients with low disease activity or in DAS28 remission who previously received conventional disease-modifying anti-rheumatic drugs.
    Niu HQ; Li ZH; Zhao WP; Zhao XC; Zhang C; Luo J; Lu XC; Gao C; Wang CH; Li XF
    Clin Exp Rheumatol; 2020; 38(1):58-66. PubMed ID: 31074719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No predictive effect of body mass index on clinical response in patients with rheumatoid arthritis after 24 weeks of biological disease-modifying antirheumatic drugs: a single-center study.
    Kim SK; Choe JY; Park SH; Lee H
    Clin Rheumatol; 2016 May; 35(5):1129-36. PubMed ID: 26932795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis.
    Yang B; Tan X; Xiong X; Wu D; Zhang G; Wang M; Dong S; Liu W; Yang H; Li Q
    Immunol Res; 2017 Jun; 65(3):592-604. PubMed ID: 27837410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study.
    Stradner MH; Dejaco C; Brickmann K; Graninger WB; Brezinschek HP
    Arthritis Res Ther; 2016 Aug; 18(1):190. PubMed ID: 27558631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
    Nakayamada S; Kubo S; Yoshikawa M; Miyazaki Y; Yunoue N; Iwata S; Miyagawa I; Hirata S; Nakano K; Saito K; Tanaka Y
    Rheumatology (Oxford); 2018 Jan; 57(1):164-174. PubMed ID: 28371836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
    Sellam J; Rouanet S; Hendel-Chavez H; Abbed K; Sibilia J; Tebib J; Le Loët X; Combe B; Dougados M; Mariette X; Taoufik Y
    Arthritis Rheum; 2011 Dec; 63(12):3692-701. PubMed ID: 22127692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research.
    Maeda S; Osaga S; Maeda T; Takeda N; Tamechika SY; Naniwa T; Niimi A
    PLoS One; 2019; 14(11):e0215192. PubMed ID: 31747403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.
    Lepse N; Abdulahad WH; Rutgers A; Kallenberg CG; Stegeman CA; Heeringa P
    Rheumatology (Oxford); 2014 Sep; 53(9):1683-92. PubMed ID: 24729403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.
    Sellam J; Rouanet S; Hendel-Chavez H; Miceli-Richard C; Combe B; Sibilia J; Le Loët X; Tebib J; Jourdan R; Dougados M; Taoufik Y; Mariette X
    Arthritis Rheum; 2013 Sep; 65(9):2253-61. PubMed ID: 23740460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24
    Körber N; Pohl L; Weinberger B; Grubeck-Loebenstein B; Wawer A; Knolle PA; Roggendorf H; Protzer U; Bauer T
    Front Immunol; 2021; 12():713351. PubMed ID: 34566969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis.
    Hsieh TY; Lui SW; Lu JW; Chen YC; Lin TC; Jheng WL; Ho YJ; Liu FC
    In Vivo; 2023; 37(5):2018-2027. PubMed ID: 37652509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis.
    Lee JS; Ahmad H; Shim SC; Bae SC; Song YW; Lee EY
    Patient; 2019 Jun; 12(3):319-326. PubMed ID: 30484084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of synovial fluid CD19
    Guo X; Xu T; Zheng J; Cui X; Li M; Wang K; Su M; Zhang H; Zheng K; Sun C; Song S; Liu H
    Sci Rep; 2020 Sep; 10(1):14386. PubMed ID: 32873834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell depletion treatment decreases Th17 cells in patients with rheumatoid arthritis.
    Bounia CA; Liossis SC
    Clin Immunol; 2021 Dec; 233():108877. PubMed ID: 34740842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Gαq impairs regulatory B-cell function.
    He Y; Yuan X; Li Y; Zhong C; Liu Y; Qian H; Xuan J; Duan L; Shi G
    Arthritis Res Ther; 2018 Aug; 20(1):186. PubMed ID: 30143054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of memory B cells are associated with response to a first tumor necrosis factor inhibitor in patients with rheumatoid arthritis in a longitudinal prospective study.
    Daien CI; Gailhac S; Mura T; Combe B; Hahne M; Morel J
    Arthritis Res Ther; 2014 Apr; 16(2):R95. PubMed ID: 24735586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.